Ebtihag O Alenzi1, Usha Sambamoorthi2. 1. Department of Pharmaceutical Systems and Policy, School of Pharmacy, West Virginia University, Morgantown, WV, 26506, USA. eoalenzi@mix.wvu.edu. 2. Department of Pharmaceutical Systems and Policy, School of Pharmacy, West Virginia University, Morgantown, WV, 26506, USA.
Abstract
BACKGROUND: Previous findings regarding depression treatment and its consequences on health-related quality of life (HRQoL) of adults with diabetes were inconsistent and targeted certain groups of population. Therefore, there is a critical need to conduct a population-based study that focuses on a general population with diabetes and depression. OBJECTIVE: The primary aim of this study was to examine the physical and mental HRQoL associated with depression treatment during the follow-up year. METHODS: We adopted a longitudinal design using multiple panels (2005-2011) of the Medical Expenditure Panel Survey to create a baseline year and follow-up year. We included adults with diabetes and depression. We categorized the baseline depression treatment into: (1) antidepressant use only; (2) psychotherapy with or without antidepressants; and (3) no treatment. HRQOL was measured using SF-12 version 2 physical component summary (PCS) and SF-12 mental component summary (MCS) scores during both baseline year and follow-up year. Ordinary least squares (OLS) were used to estimate the association between depression treatment and the HRQoL measures. The OLS regression controlled for predisposing, enabling, need, external environment factors, personal health practices, and baseline HRQoL measures. RESULTS: After controlling for all the independent variables and the baseline PCS, individuals who received psychotherapy with or without antidepressants had higher PCS scores as compared to those without any treatment for depression (beta = 1.28, p < 0.001). Individuals who reported using only antidepressants had lower PCS scores (beta = -0.54, p < 0.001) as compared to those without depression treatment. On the contrary, individuals who reported receiving psychotherapy with or without antidepressants had lower MCS scores as compared to those without depression treatment (beta = -1.43, p < 0.001). Those using only antidepressants had higher MCS scores as compared to those without depression treatment (beta = 0.56, p < 0.001). CONCLUSION: The associations between depression treatment and the HRQoL varied by the type of depression treatment and the component of the HRQoL measures.
BACKGROUND: Previous findings regarding depression treatment and its consequences on health-related quality of life (HRQoL) of adults with diabetes were inconsistent and targeted certain groups of population. Therefore, there is a critical need to conduct a population-based study that focuses on a general population with diabetes and depression. OBJECTIVE: The primary aim of this study was to examine the physical and mental HRQoL associated with depression treatment during the follow-up year. METHODS: We adopted a longitudinal design using multiple panels (2005-2011) of the Medical Expenditure Panel Survey to create a baseline year and follow-up year. We included adults with diabetes and depression. We categorized the baseline depression treatment into: (1) antidepressant use only; (2) psychotherapy with or without antidepressants; and (3) no treatment. HRQOL was measured using SF-12 version 2 physical component summary (PCS) and SF-12 mental component summary (MCS) scores during both baseline year and follow-up year. Ordinary least squares (OLS) were used to estimate the association between depression treatment and the HRQoL measures. The OLS regression controlled for predisposing, enabling, need, external environment factors, personal health practices, and baseline HRQoL measures. RESULTS: After controlling for all the independent variables and the baseline PCS, individuals who received psychotherapy with or without antidepressants had higher PCS scores as compared to those without any treatment for depression (beta = 1.28, p < 0.001). Individuals who reported using only antidepressants had lower PCS scores (beta = -0.54, p < 0.001) as compared to those without depression treatment. On the contrary, individuals who reported receiving psychotherapy with or without antidepressants had lower MCS scores as compared to those without depression treatment (beta = -1.43, p < 0.001). Those using only antidepressants had higher MCS scores as compared to those without depression treatment (beta = 0.56, p < 0.001). CONCLUSION: The associations between depression treatment and the HRQoL varied by the type of depression treatment and the component of the HRQoL measures.
Authors: John W Williams; Wayne Katon; Elizabeth H B Lin; Polly H Nöel; Jason Worchel; John Cornell; Linda Harpole; Bridget A Fultz; Enid Hunkeler; Virginia S Mika; Jürgen Unützer Journal: Ann Intern Med Date: 2004-06-15 Impact factor: 25.391
Authors: Marianne McCollum; Samuel L Ellis; Judith G Regensteiner; Weiming Zhang; Patrick W Sullivan Journal: Am J Manag Care Date: 2007-02 Impact factor: 2.229
Authors: Wayne J Katon; Michael Von Korff; Elizabeth H B Lin; Greg Simon; Evette Ludman; Joan Russo; Paul Ciechanowski; Edward Walker; Terry Bush Journal: Arch Gen Psychiatry Date: 2004-10
Authors: Ingrid E Lobo; Danielle F Loeb; Vahram Ghushchyan; Irene E Schauer; Amy G Huebschmann Journal: Prev Chronic Dis Date: 2012 Impact factor: 2.830
Authors: Victor Okunrintemi; Javier Valero-Elizondo; Erin D Michos; Joseph A Salami; Oluseye Ogunmoroti; Chukwuemeka Osondu; Martin Tibuakuu; Eve-Marie Benson; Timothy M Pawlik; Michael J Blaha; Khurram Nasir Journal: J Gen Intern Med Date: 2019-09-05 Impact factor: 5.128
Authors: S C Danhauer; G A Brenes; B J Levine; L Young; H A Tindle; E L Addington; R B Wallace; M J Naughton; L Garcia; M Safford; M M Kim; E S LeBlanc; B M Snively; L G Snetselaar; S Shumaker Journal: Diabet Med Date: 2019-02-28 Impact factor: 4.359
Authors: Ke Han; Shanshan Yang; Wangping Jia; Shengshu Wang; Yang Song; Wenzhe Cao; Jianwei Wang; Miao Liu; Yao He Journal: Front Public Health Date: 2020-10-30